It is Poised to be a Bull Market for Organogenesis Holdings Inc (ORGO)

With 1.22 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.66 million shares. The 52-week range on ORGO shows that it touched its highest point at $6.71 and its lowest point at $2.16 during that stretch. It currently has a 1-year price target of $6.00. Beta for the stock currently stands at 1.73.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ORGO was down-trending over the past week, with a drop of -5.18%, but this was up by 44.51% over a month. Three-month performance surged to 34.65% while six-month performance rose 94.32%. The stock gained 80.00% in the past year, while it has gained 60.31% so far this year. A look at the trailing 12-month EPS for ORGO yields 0.01 with Next year EPS estimates of 0.17. For the next quarter, that number is -0.04. This implies an EPS growth rate of 475.00% for this year and 344.45% for next year.

Float and Shares Shorts:

At present, 125.73 million ORGO shares are outstanding with a float of 64.38 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ORGO since 3 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.06285686 being high and -$0.08380914 being low. For ORGO, this leads to a yearly average estimate of -$0.073333. Based on analyst estimates, the high estimate for the next quarter is $0.03 and the low estimate is $0.03. The average estimate for the next quarter is thus $0.03.